AptarGroup (ATR) Stock: Buy, Sell, or Hold?
ATR - AptarGroup, Inc.
$124.84
1.79 (1.45%)
▲
5d:
-2.7%
30d:
-6.24%
90d:
+7.09%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When ATR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ATR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ATR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$202.93
Based on 9.3% avg growth
INTRINSIC VALUE TODAY
$126.00
0.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATR is currently trading at $124.84, which is considered oversold relative to its 30-day fair value range of $127.75 to $135.68. The stock's valuation (Forward PE: 19.8) is in line with its historical norms (20.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATR is in a strong uptrend. Immediate support is located at $120.74, while resistance sits at $133.66.
Market Sentiment: ATR scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $170.14 (+36.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATR is in a strong uptrend. Immediate support is located at $120.74, while resistance sits at $133.66.
Market Sentiment: ATR scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $170.14 (+36.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$127.75 -
$135.68
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding ATR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.3% below Wall St target ($170.14)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$127.75 -
$135.68
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.51
(3.6%)
Support & Resistance Levels
Support Level
$120.74
Resistance Level
$133.66
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.76
Wall Street Target
$170.14
(+36.3%)
Revenue Growth (YoY)
6.3%
Earnings Growth (YoY)
-18.6%
Profit Margin
9.2%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
19.8 vs 20.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$122.97
(-2%)
2-Year Target
$121.12
(-3%)
3-Year Target
$119.31
(-4%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$124.97
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 14.5%)
$191.27
(+53%)
Base:
(SPY PE: 19.8, Growth: 14.5%)
$187.40
(+50%)
Bear:
(PE: 16.8, Growth: 14.5%)
$159.29
(+28%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 22.01 | Current EPS (TTM): $5.59
Bull Case
$152.96
(+23%)
Analyst growth 13.0%, PE expands to 24.2
Base Case
$139.06
(+11%)
Market implied 13.0%, PE stable at 22.0
Bear Case
$83.67
(-33%)
Severe decline -20.0%, PE contracts to 18.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.8 to 20.7
Stabilization Target:
$130.76
(+4.7%)
PE Expansion Potential:
+4.7%
Share & Embed Analysis
Last updated: September 12, 2026 2:00 AM ET
Data refreshes hourly during market hours. Next update: 3:00 AM
Data refreshes hourly during market hours. Next update: 3:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced ATR Option Strategies
Professional options setups generated by AI based on today's ATR price and gamma walls.
